Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wang L et al. – In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers. FOXP3 is an X–linked prostate tumor suppressor in the male. Because the male has only one X chromosome, our data represent a paradigm of “single genetic hit” inactivation–mediated carcinogenesis.

Today in Carcinogenesis...keeping you current

Association of rare MSH6 variants with familial breast cancer
Breast Cancer Research and Treatment, 11/24/09

APC promoter hypermethylation is an early event in endometrial tumorigenesis
Cancer Science, 11/16/09

Biological role of NHERF1 protein expression in breast cancer
Histopathology, 11/12/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address